LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2 alpha-ATF4-CHOP axis
LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2 alpha-ATF4-CHOP axis
复制标题
LW-213 通过激活 PERK-eIF2α-ATF4-CHOP 轴诱导人皮肤 T 细胞淋巴瘤细胞凋亡
DOI:
10.1038/s41401-020-0466-7
复制
发表时间:
2020
影响因子:
8.2
通讯作者:
Hui Hui
中科院分区:
文献类型:
--
作者:
Yu Xiao-xuan;Zhu Meng-yuan;Wang Jia-rong;Li Hui;Hu Po;Qing Ying-jie;Wang Xiang-yuan;Wang Hong-zheng;Wang Zhan-yu;Xu Jing-yan;Guo Qing-long;Hui Hui
Cutaneous T-cell lymphoma (CTCL) is characterized by a heterogeneous group of extranodal non-Hodgkin lymphomas, in which monoclonal T lymphocytes infiltrate the skin. LW-213, a derivative of wogonin, was found to induce cell apoptosis in chronic myeloid leukemia (CML). In this study, we investigated the effects of LW-213 on CTCL cells and the underlying mechanisms. We showed that LW-213 (1–25 μM) dose-dependently inhibited human CTCL cell lines (Hut-102, Hut-78, MyLa, and HH) with IC50values of around 10 μM, meanwhile it potently inhibited primary leukemia cells derived from peripheral blood of T-cell lymphoma patients. We revealed that LW-213-induced apoptosis was accompanied by ROS formation and the release of calcium from endoplasmic reticulum (ER) through IP3R-1channel. LW-213 selectively activated CHOP and induced apoptosis in Hut-102 cells via activating PERK–eIF2α–ATF4 pathway. Interestingly, the degree of apoptosis and expression of ER stress-related proteins were alleviated in the presence of either N-acetyl cysteine (NAC), an ROS scavenger, or 2-aminoethyl diphenylborinate (2-APB), an IP3R-1 inhibitor, implicating ROS/calcium-dependent ER stress in LW-213-induced apoptosis. InNOD/SCIDmice bearing Hut-102 cell line xenografts, administration of LW-213 (10 mg/kg, ip, every other day for 4 weeks) markedly inhibited the growth of Hut-102 derived xenografts and prolonged survival. In conclusion, our study provides a new insight into the mechanism of LW-213-induced apoptosis, suggesting the potential of LW-213 as a promising agent against CTCL.